[
Barcellini L., E. Borroni, J. Brown, E. Brunetti, L. Codecasa, F. Cugnata, P.D. Monte, C.D. Serio, D. Goletti and others. 2016. First independent evaluation of QuantiFERON-TB Plus performance. Eur. Respir. J. http://erj.ersjournals.com/content/47/5/1587. long, 2016.04.30.
]Search in Google Scholar
[
Borkowska D., Z. Zwolska, D. Michałowska-Mitczuk, M. Korzeniewska-Koseła, A. Zabost, A. Napiórkowska, M. Kozińska, S. Krzezińska and E. Augustynowicz-Kopeć. 2011. Interferongamma assay T-SPOT.TB in the diagnostics of latent tuberculosis infection. Pneumonol. Alergol. Pol. 79: 264–271.10.5603/ARM.27644
]Search in Google Scholar
[
Diel R, R. Loddenkemper and A. Nienhaus. 2010. Evidence-based comparison of commercial interferon-γ release assays for detecting active TB. Chest 137: 952–968.10.1378/chest.09-235020022968
]Search in Google Scholar
[
Diel R., D. Goletti, G. Ferrara, G. Bothamley, D. Cirillo, B. Kampmann, C. Lange, M. Losi, R. Markova, G.B. Migliori and others. 2011. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and metaanalysis. Eur. Respir. J. 37: 88–99.10.1183/09031936.0011511021030451
]Search in Google Scholar
[
European Centre for Disease Prevention and Control (ECDC). 2011. Use of interferon-gamma release assays in support of TB diagnosis, pp. 1–32. ECDC. Stockholm.
]Search in Google Scholar
[
Getahun H., R.E. Chaisson and M. Raviglione. 2015. Latent Mycobacterium tuberculosis infection. N. Engl. J. Med. 373: 1179–1180.10.1056/NEJMc150822326376149
]Search in Google Scholar
[
Hermansen T.S., T. Lillebaek, K.L. Kristensen, P.H. Andersen and P. Ravn. 2016. Prognostic value of interferon-γ release assays, a population-based study from a TB low-incidence country. Thorax. 71: 652–658.
]Search in Google Scholar
[
Hoffmann H, K. Avsar, R. Göres, S.C. Mavi and S. Hofmann-Thiel. 2016. Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT. Clin. Microbiol. Infect. http://www.ncbi.nlm.nih.gov/pubmed/27184875, 2016.04.30.
]Search in Google Scholar
[
van Ingen J., R. de Zwaan, R. Dekhuijzen, M. Boeree and D. van Soolingen. 2009. Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character. J. Bacteriol. 191: 5865–5867.10.1128/JB.00683-09273794319617365
]Search in Google Scholar
[
Kang Y.A., H.W. Lee, H.I. Yoon, B. Cho, S.K. Han, Y.S. Shim and J.J. Jim. 2005. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293: 2756–2785.10.1001/jama.293.22.275615941805
]Search in Google Scholar
[
Korzeniewska-Koseła M. 2016. Tuberculosis and lung diseases in Poland in 2015. (In Polish). Institute Tuberculosis and Lung Diseases, Warsaw.
]Search in Google Scholar
[
Kruczak K., W. Skucha, M. Duplaga, M. Sanak and E. Niżan-kowska-Mogilnicka. 2009. Assessment of the latent tuberculosis infection (LTBI) with QuantiFERON-GIT (QFT-GIT) assay in selected risk groups in Krakow. (In Polish) Borgis – Nowa Medycyna 1: 37–42.
]Search in Google Scholar
[
Lalvani A. 2007. Diagnosing tuberculosis infection in the 21st century. New tools to tackle an old enemy. Chest 131: 1898–1906.10.1378/chest.06-247117565023
]Search in Google Scholar
[
Lim W.S. 2016. From latent to active TB: are IGRAs of any use? Thorax. 71: 585–586.10.1136/thoraxjnl-2016-20895527302631
]Search in Google Scholar
[
Mack U., G.B. Migliori, M. Sester, H.L. Rieder, S. Ehlers, D. Goletti, A. Bossink, K. Magdorf, C. Hölscher, B. Kampmann and others. 2009. LTBI: latent tuberculosis infection or lasting immune responses to Mycobacterium tuberculosis? A TBNET consensus statement. Eur. Respir. J. 33: 956–973.10.1183/09031936.0012090819407047
]Search in Google Scholar
[
Menzies D., M. Pai and G. Comstock. 2007. Meta-analysis: new tests in the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 146: 340–354.10.7326/0003-4819-146-5-200703060-0000617339619
]Search in Google Scholar
[
Pai M., C.M. Denkinger, S.V. Kik, M.X. Rangaka, A. Zwerling, O. Oxlade, J.Z. Metcalfe, A. Cattamanchi, D.W. Dowdy, K. Dheda and others. 2014. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin. Microbiol. Rev. 27: 3–20.10.1128/CMR.00034-13391090824396134
]Search in Google Scholar
[
QuantiFeron-TB Gold Plus (QFT-Plus) ELISA package insert. http://www.quantiferon.com/irm/content/PI/QFT/PLUS/2PK-Elisa/UK.pdf, 2016.04.30.
]Search in Google Scholar
[
Rangaka M.X., K.A. Wilkinson, J.R. Glynn, D. Ling, D. Menzies, J. Mwansa-Kambafwile, K. Fielding, R.J. Wilkinson and M. Pai. 2012. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta analysis. Lancet Infect. Dis. 12: 45–55.10.1016/S1473-3099(11)70210-9
]Search in Google Scholar
[
Salgame P., C. Geadas, L. Collins, E. Jones-Lopez, J.J. Ellner. 2015. Latent tuberculosis infection – Revisiting and revising concepts. Tuberculosis. 95: 373–384.10.1016/j.tube.2015.04.003
]Search in Google Scholar
[
Sester M., G. Sotgiu, C. Lange, C. Giehl, E. Girardi, G.B. Migliori, A. Bossink, K. Dheda, R. Diel, J. Dominguez and others. 2011. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur. Respir. J. 37: 100–111.10.1183/09031936.00114810
]Search in Google Scholar
[
Sloot R., M.F. Schim van der Loeff, P.M. Kouw and M.W.
]Search in Google Scholar
[
Borgdorff. 2014. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am. J. Respir. Crit. Care Med. 190: 1044–1052.10.1164/rccm.201406-1159OC
]Search in Google Scholar
[
Trajman A., R.E. Steffen and D. Menzies. 2013. Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: An overview of the evidence. Pulm. Med. 601737. http://dx.doi.org/10.1155/2013/601737, 2016.04.30.10.1155/2013/601737
]Search in Google Scholar
[
T-SPOT.TB packane insert. 2013. http://www.oxfordimmunotec. com/north-america/wp-content/uploads/sites/2/T-SPOT-PI-TB-US-v4.pdf, 2016.04.30.
]Search in Google Scholar
[
Turetz M.L. and K.C. Ma. 2016. Diagnosis and management of latent tuberculosis. Curr. Opin. Infect. Dis. 29: 205–211.10.1097/QCO.0000000000000253
]Search in Google Scholar
[
Uplekar M., D. Weil, K. Lonnroth, E. Jaramillo, C. Lienhardt, H.M. Dias, D. Falzon, K. Floyd, G. Gargioni, H. Getahun and others. 2016. WHO’s new end TB strategy. Lancet 385: 1799–1801.10.1016/S0140-6736(15)60570-0
]Search in Google Scholar
[
World Health Organization (WHO). 2008. Global tuberculosis control: surveillance, planning, financing, pp. 1–294. WHO. Geneva.
]Search in Google Scholar
[
Zellweger J.P., G. Sotgiu, M. Block, S. Dore, N. Altet, R. Blunschi, M. Bogyi, G. Bothamley, C. Bothe, L. Codecasa and others. 2015. Risk assessment of tuberculosis in contacts by IFN-γ release assays. A tuberculosis network European Trial Group Study. Am. J. Respir. Crit. Care Med. 191: 1176–1184.10.1164/rccm.201502-0232OC25763458
]Search in Google Scholar
